DOI: 10.1053/gast.2001.24844. Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth

Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth

10.1053/gast.2001.24844

Crossref journal-article

Elsevier BV

Gastroenterology (78)

Bibliography

Mann, M., Sheng, H., Shao, J., Williams, C. S., Dubois, R. N., Pisacane, P. I., & Sliwkowski, M. X. (2001). Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth. Gastroenterology, 120(7), 1713â1719.

Authors 7

Moss Mann (first)
Hongmiao Sheng (additional)
Jinyi Shao (additional)
Christopher S. Williams (additional)
Raymond N. Dubois (additional)
Paul I. Pisacane (additional)
Mark X. Sliwkowski (additional)

References 45 Referenced 138

10.1097/00001622-199901000-00003 / Curr Opin Oncol / The biology and treatment of progranulocytic leukemia by Slack (1999)
10.1016/S0959-8049(99)00314-7 / Eur J Cancer / New directions in the treatment of colorectal cancer: a look to the future by Sobrero (2000)
10.1016/0016-5085(94)90246-1 / Gastroenterology / Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas by Eberhart (1994)
10.1016/S0002-9440(10)64759-1 / Am J Pathol / Localization of cyclooxygenase-2 in human sporadic colorectal adenoma by Chapple (2000)
{'key': '10.1053/gast.2001.24844_bib5', 'first-page': '2556', 'article-title': 'Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer', 'volume': '55', 'author': 'Kargman', 'year': '1995', 'journal-title': 'Cancer Res'} / Cancer Res / Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer by Kargman (1995)
{'key': '10.1053/gast.2001.24844_bib6', 'first-page': '3785', 'article-title': 'Expression of cyclooxygenase-1 and -2 in human colorectal cancer', 'volume': '55', 'author': 'Sano', 'year': '1995', 'journal-title': 'Cancer Res'} / Cancer Res / Expression of cyclooxygenase-1 and -2 in human colorectal cancer by Sano (1995)
10.1038/sj.onc.1203286 / Oncogene / The role of cyclooxygenases in inflammation, cancer and development by Williams (1999)
10.1111/j.1749-6632.2000.tb06709.x / Ann N Y Acad Sci / Translational studies on COX-2 inhibitors in the prevention and treatment of colorectal cancer by Gupta (2000)
{'key': '10.1053/gast.2001.24844_bib9', 'first-page': '409', 'article-title': 'Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis', 'volume': '58', 'author': 'Kawamori', 'year': '1998', 'journal-title': 'Cancer Res'} / Cancer Res / Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis by Kawamori (1998)
{'key': '10.1053/gast.2001.24844_bib10', 'first-page': '4566', 'article-title': 'Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis', 'volume': '56', 'author': 'Reddy', 'year': '1996', 'journal-title': 'Cancer Res'} / Cancer Res / Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis by Reddy (1996)
{'key': '10.1053/gast.2001.24844_bib11', 'first-page': '1864', 'article-title': 'Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos', 'volume': '60', 'author': 'Jacoby', 'year': '2000', 'journal-title': 'Cancer Res'} / Cancer Res / Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos by Jacoby (2000)
10.1056/NEJM200006293422603 / N Engl J Med / The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis by Steinbach (2000)
10.1016/S0065-230X(08)60784-8 / Adv Cancer Res / Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors by Klapper (2000)
10.1093/emboj/19.13.3159 / EMBO J / The ErbB signaling network: receptor heterodimerization in development and cancer by Monilola (2000)
10.1023/A:1018762216147 / J Mammary Gland Biol Neoplasia / The ErbB receptors as targets for breast cancer therapy by Albanell (1999)
10.1038/bjc.1991.30 / Br J Cancer / Epidermal growth factor receptor (EGFR); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup by Nicholson (1991)
10.1126/science.3798106 / Science / Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene by Slamon (1987)
10.3233/BD-1999-11109 / Breast Dis / Development of Herceptin by Carter (2000)
10.1200/JCO.1999.17.9.2639 / J Clin Oncol / Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease by Cobleigh (1999)
{'issue': 'suppl 12', 'key': '10.1053/gast.2001.24844_bib20', 'first-page': '60', 'article-title': 'Nonclinical studies addressing the mechanism of action of Herceptin® (trastuzumab)', 'volume': '26', 'author': 'Sliwkowski', 'year': '1999', 'journal-title': 'Semin Oncol'} / Semin Oncol / Nonclinical studies addressing the mechanism of action of Herceptin® (trastuzumab) by Sliwkowski (1999)
10.1016/S0016-5085(97)70120-3 / Gastroenterology / The expression of p185(HER-2/neu) correlates with the stage of disease and survival in colorectal cancer by Kapitanovic (1997)
{'key': '10.1053/gast.2001.24844_bib22', 'first-page': '240', 'article-title': 'Association of epidermal growth factor-related peptides and type I receptor tyrosine kinase receptors with prognosis of human colorectal carcinomas', 'volume': '25', 'author': 'Saeki', 'year': '1995', 'journal-title': 'Jpn J Clin Oncol'} / Jpn J Clin Oncol / Association of epidermal growth factor-related peptides and type I receptor tyrosine kinase receptors with prognosis of human colorectal carcinomas by Saeki (1995)
10.1038/79534 / Nature Med / Combinatorial chemoprevention of intestinal neoplasia by Torrance (2000)
10.1038/79664 / Nature Med / Combinations for cancer prevention by Gupta (2000)
10.1002/path.1711700407 / J Pathol / Isolation and characterization of multiple cell types from a single human colonic carcinoma: tumorigenicity of these cell types in a xenograft system by Marsh (1993)
{'key': '10.1053/gast.2001.24844_bib26', 'first-page': '1457', 'article-title': 'Growth regulation of human breast and ovarian tumor cells by heregulin: evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness', 'volume': '56', 'author': 'Lewis', 'year': '1996', 'journal-title': 'Cancer Res'} / Cancer Res / Growth regulation of human breast and ovarian tumor cells by heregulin: evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness by Lewis (1996)
10.1038/sj.onc.1201317 / Oncogene / β-Heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast tumor cell line, MDA-MB-175 by Schaefer (1997)
10.1016/S0021-9258(17)36676-0 / J Biol Chem / Coexpression of ErbB2 and ErbB3 proteins reconstitutes a high affinity receptor for heregulin by Sliwkowski (1994)
10.1101/gr.6.10.995 / Genome Res / A novel method for real time quantitative PCR by Gibson (1996)
10.1101/gr.6.10.986 / Genome Res / Real time quantitative PCR by Heid (1996)
10.1038/sj.onc.1202993 / Oncogene / Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells by Aguilar (1999)
10.1172/JCI119400 / J Clin Invest / Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2 by Sheng (1997)
{'key': '10.1053/gast.2001.24844_bib33', 'first-page': '732', 'article-title': 'Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes', 'volume': '58', 'author': 'Brossart', 'year': '1998', 'journal-title': 'Cancer Res'} / Cancer Res / Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes by Brossart (1998)
10.1038/sj.onc.1202307 / Oncogene / Regulation of cyclooxygenase-2 pathway by HER2 receptor by Vadlamudi (1999)
10.1016/S0092-8674(00)81333-1 / Cell / Lessons from hereditary colorectal cancer by Kinzler (1996)
10.1016/S0092-8674(00)81433-6 / Cell / Cyclooxygenase regulates angiogenesis induced by colon cancer cells by Tsujii (1998)
10.1073/pnas.94.7.3336 / Proc Natl Acad Sci U S A / Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential by Tsujii (1997)
10.1172/JCI9621 / J Clin Invest / DuBois RN. Host cyclo-oxygenase-2 modulates carcinoma growth by Williams (2000)
10.1002/(SICI)1097-4644(2000)77:34+<52::AID-JCB10>3.0.CO;2-X / J Cell Biochem Suppl / The ErbB/HER family of receptor tyrosine kinases: a potential target for chemoprevention of epithelial neoplasms by Kirschbaum (2000)
10.1046/j.1365-2559.2001.01084.x / Histopathology / Overexpression of HER2/new in solid tumors: an immunohistochemical survey by Koeppen (2001)
10.1073/pnas.94.2.657 / Proc Natl Acad Sci U S A / EGF receptor activation induces nuclear targeting of COX-2, basolateral release of prostaglandins and mitogenesis in polarizing colon cancer cells by Coffey (1997)
10.1016/S1388-1981(99)00034-7 / Biochim Biophys Acta / Growth stimulation and induction of epidermal growth factor receptor by overexpression of cyclooxygenases 1 and 2 in human colon carcinoma cells by Kinoshita (1999)
10.1016/S0304-3835(98)00254-7 / Cancer Lett / Decreased HER-2 tyrosine kinase expression in rectal mucosa of FAP patients following low-dose sulindac chemoprevention by Winde (1998)
10.1161/01.CIR.102.3.272 / Circulation / Trastuzumab in the treatment of metastatic breast cancer: anticancer therapy versus cardiotoxicity by Feldman (2000)
{'key': '10.1053/gast.2001.24844_bib45', 'first-page': '3', 'article-title': 'Site-directed irreversible inhibitors of the ErbB family of receptor tyrosine kinases as novel chemotherapeutic agents for cancer', 'volume': '15', 'author': 'Fry', 'year': '2000', 'journal-title': 'Anticancer Drug Des'} / Anticancer Drug Des / Site-directed irreversible inhibitors of the ErbB family of receptor tyrosine kinases as novel chemotherapeutic agents for cancer by Fry (2000)

Dates

Type	When
Created	20 years, 1 month ago (July 29, 2005, 1:58 p.m.)
Deposited	4 years, 1 month ago (July 14, 2021, 1:59 a.m.)
Indexed	1 month, 3 weeks ago (July 12, 2025, 6:51 p.m.)
Issued	24 years, 3 months ago (June 1, 2001)
Published	24 years, 3 months ago (June 1, 2001)
Published Print	24 years, 3 months ago (June 1, 2001)

Funders 0

None

BibTeX

@article{Mann_2001, title={Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth}, volume={120}, ISSN={0016-5085}, url={http://dx.doi.org/10.1053/gast.2001.24844}, DOI={10.1053/gast.2001.24844}, number={7}, journal={Gastroenterology}, publisher={Elsevier BV}, author={Mann, Moss and Sheng, Hongmiao and Shao, Jinyi and Williams, Christopher S. and Dubois, Raymond N. and Pisacane, Paul I. and Sliwkowski, Mark X.}, year={2001}, month=jun, pages={1713–1719} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        7,
        12
      ]
    ],
    "date-time": "2025-07-12T22:51:25Z",
    "timestamp": 1752360685267
  },
  "reference-count": 45,
  "publisher": "Elsevier BV",
  "issue": "7",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            2001,
            6,
            1
          ]
        ],
        "date-time": "2001-06-01T00:00:00Z",
        "timestamp": 991353600000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2001,
        6
      ]
    ]
  },
  "DOI": "10.1053/gast.2001.24844",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2005,
        7,
        29
      ]
    ],
    "date-time": "2005-07-29T17:58:00Z",
    "timestamp": 1122659880000
  },
  "page": "1713-1719",
  "source": "Crossref",
  "is-referenced-by-count": 138,
  "title": "Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth",
  "prefix": "10.1053",
  "volume": "120",
  "author": [
    {
      "given": "Moss",
      "family": "Mann",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "Hongmiao",
      "family": "Sheng",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Jinyi",
      "family": "Shao",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Christopher S.",
      "family": "Williams",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Raymond N.",
      "family": "Dubois",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Paul I.",
      "family": "Pisacane",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Mark X.",
      "family": "Sliwkowski",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "78",
  "reference": [
    {
      "key": "10.1053/gast.2001.24844_bib1",
      "doi-asserted-by": "crossref",
      "first-page": "9",
      "DOI": "10.1097/00001622-199901000-00003",
      "article-title": "The biology and treatment of progranulocytic leukemia",
      "volume": "11",
      "author": "Slack",
      "year": "1999",
      "journal-title": "Curr Opin Oncol"
    },
    {
      "key": "10.1053/gast.2001.24844_bib2",
      "doi-asserted-by": "crossref",
      "first-page": "559",
      "DOI": "10.1016/S0959-8049(99)00314-7",
      "article-title": "New directions in the treatment of colorectal cancer: a look to the future",
      "volume": "36",
      "author": "Sobrero",
      "year": "2000",
      "journal-title": "Eur J Cancer"
    },
    {
      "key": "10.1053/gast.2001.24844_bib3",
      "doi-asserted-by": "crossref",
      "first-page": "1183",
      "DOI": "10.1016/0016-5085(94)90246-1",
      "article-title": "Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas",
      "volume": "107",
      "author": "Eberhart",
      "year": "1994",
      "journal-title": "Gastroenterology"
    },
    {
      "key": "10.1053/gast.2001.24844_bib4",
      "doi-asserted-by": "crossref",
      "first-page": "545",
      "DOI": "10.1016/S0002-9440(10)64759-1",
      "article-title": "Localization of cyclooxygenase-2 in human sporadic colorectal adenoma",
      "volume": "156",
      "author": "Chapple",
      "year": "2000",
      "journal-title": "Am J Pathol"
    },
    {
      "key": "10.1053/gast.2001.24844_bib5",
      "first-page": "2556",
      "article-title": "Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer",
      "volume": "55",
      "author": "Kargman",
      "year": "1995",
      "journal-title": "Cancer Res"
    },
    {
      "key": "10.1053/gast.2001.24844_bib6",
      "first-page": "3785",
      "article-title": "Expression of cyclooxygenase-1 and -2 in human colorectal cancer",
      "volume": "55",
      "author": "Sano",
      "year": "1995",
      "journal-title": "Cancer Res"
    },
    {
      "key": "10.1053/gast.2001.24844_bib7",
      "doi-asserted-by": "crossref",
      "first-page": "7908",
      "DOI": "10.1038/sj.onc.1203286",
      "article-title": "The role of cyclooxygenases in inflammation, cancer and development",
      "volume": "18",
      "author": "Williams",
      "year": "1999",
      "journal-title": "Oncogene"
    },
    {
      "key": "10.1053/gast.2001.24844_bib8",
      "doi-asserted-by": "crossref",
      "first-page": "196",
      "DOI": "10.1111/j.1749-6632.2000.tb06709.x",
      "article-title": "Translational studies on COX-2 inhibitors in the prevention and treatment of colorectal cancer",
      "volume": "910",
      "author": "Gupta",
      "year": "2000",
      "journal-title": "Ann N Y Acad Sci"
    },
    {
      "key": "10.1053/gast.2001.24844_bib9",
      "first-page": "409",
      "article-title": "Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis",
      "volume": "58",
      "author": "Kawamori",
      "year": "1998",
      "journal-title": "Cancer Res"
    },
    {
      "key": "10.1053/gast.2001.24844_bib10",
      "first-page": "4566",
      "article-title": "Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis",
      "volume": "56",
      "author": "Reddy",
      "year": "1996",
      "journal-title": "Cancer Res"
    },
    {
      "key": "10.1053/gast.2001.24844_bib11",
      "first-page": "1864",
      "article-title": "Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos",
      "volume": "60",
      "author": "Jacoby",
      "year": "2000",
      "journal-title": "Cancer Res"
    },
    {
      "key": "10.1053/gast.2001.24844_bib12",
      "doi-asserted-by": "crossref",
      "first-page": "1946",
      "DOI": "10.1056/NEJM200006293422603",
      "article-title": "The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis",
      "volume": "342",
      "author": "Steinbach",
      "year": "2000",
      "journal-title": "N Engl J Med"
    },
    {
      "key": "10.1053/gast.2001.24844_bib13",
      "doi-asserted-by": "crossref",
      "first-page": "25",
      "DOI": "10.1016/S0065-230X(08)60784-8",
      "article-title": "Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors",
      "volume": "77",
      "author": "Klapper",
      "year": "2000",
      "journal-title": "Adv Cancer Res"
    },
    {
      "key": "10.1053/gast.2001.24844_bib14",
      "doi-asserted-by": "crossref",
      "first-page": "3159",
      "DOI": "10.1093/emboj/19.13.3159",
      "article-title": "The ErbB signaling network: receptor heterodimerization in development and cancer",
      "volume": "19",
      "author": "Monilola",
      "year": "2000",
      "journal-title": "EMBO J"
    },
    {
      "key": "10.1053/gast.2001.24844_bib15",
      "doi-asserted-by": "crossref",
      "first-page": "337",
      "DOI": "10.1023/A:1018762216147",
      "article-title": "The ErbB receptors as targets for breast cancer therapy",
      "volume": "4",
      "author": "Albanell",
      "year": "1999",
      "journal-title": "J Mammary Gland Biol Neoplasia"
    },
    {
      "key": "10.1053/gast.2001.24844_bib16",
      "doi-asserted-by": "crossref",
      "first-page": "146",
      "DOI": "10.1038/bjc.1991.30",
      "article-title": "Epidermal growth factor receptor (EGFR); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup",
      "volume": "63",
      "author": "Nicholson",
      "year": "1991",
      "journal-title": "Br J Cancer"
    },
    {
      "key": "10.1053/gast.2001.24844_bib17",
      "doi-asserted-by": "crossref",
      "first-page": "177",
      "DOI": "10.1126/science.3798106",
      "article-title": "Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene",
      "volume": "235",
      "author": "Slamon",
      "year": "1987",
      "journal-title": "Science"
    },
    {
      "key": "10.1053/gast.2001.24844_bib18",
      "doi-asserted-by": "crossref",
      "first-page": "103",
      "DOI": "10.3233/BD-1999-11109",
      "article-title": "Development of Herceptin",
      "volume": "11",
      "author": "Carter",
      "year": "2000",
      "journal-title": "Breast Dis"
    },
    {
      "key": "10.1053/gast.2001.24844_bib19",
      "doi-asserted-by": "crossref",
      "first-page": "2639",
      "DOI": "10.1200/JCO.1999.17.9.2639",
      "article-title": "Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease",
      "volume": "17",
      "author": "Cobleigh",
      "year": "1999",
      "journal-title": "J Clin Oncol"
    },
    {
      "issue": "suppl 12",
      "key": "10.1053/gast.2001.24844_bib20",
      "first-page": "60",
      "article-title": "Nonclinical studies addressing the mechanism of action of Herceptin\u00ae (trastuzumab)",
      "volume": "26",
      "author": "Sliwkowski",
      "year": "1999",
      "journal-title": "Semin Oncol"
    },
    {
      "key": "10.1053/gast.2001.24844_bib21",
      "doi-asserted-by": "crossref",
      "first-page": "1103",
      "DOI": "10.1016/S0016-5085(97)70120-3",
      "article-title": "The expression of p185(HER-2/neu) correlates with the stage of disease and survival in colorectal cancer",
      "volume": "112",
      "author": "Kapitanovic",
      "year": "1997",
      "journal-title": "Gastroenterology"
    },
    {
      "key": "10.1053/gast.2001.24844_bib22",
      "first-page": "240",
      "article-title": "Association of epidermal growth factor-related peptides and type I receptor tyrosine kinase receptors with prognosis of human colorectal carcinomas",
      "volume": "25",
      "author": "Saeki",
      "year": "1995",
      "journal-title": "Jpn J Clin Oncol"
    },
    {
      "key": "10.1053/gast.2001.24844_bib23",
      "doi-asserted-by": "crossref",
      "first-page": "1024",
      "DOI": "10.1038/79534",
      "article-title": "Combinatorial chemoprevention of intestinal neoplasia",
      "volume": "6",
      "author": "Torrance",
      "year": "2000",
      "journal-title": "Nature Med"
    },
    {
      "key": "10.1053/gast.2001.24844_bib24",
      "doi-asserted-by": "crossref",
      "first-page": "974",
      "DOI": "10.1038/79664",
      "article-title": "Combinations for cancer prevention",
      "volume": "6",
      "author": "Gupta",
      "year": "2000",
      "journal-title": "Nature Med"
    },
    {
      "key": "10.1053/gast.2001.24844_bib25",
      "doi-asserted-by": "crossref",
      "first-page": "441",
      "DOI": "10.1002/path.1711700407",
      "article-title": "Isolation and characterization of multiple cell types from a single human colonic carcinoma: tumorigenicity of these cell types in a xenograft system",
      "volume": "170",
      "author": "Marsh",
      "year": "1993",
      "journal-title": "J Pathol"
    },
    {
      "key": "10.1053/gast.2001.24844_bib26",
      "first-page": "1457",
      "article-title": "Growth regulation of human breast and ovarian tumor cells by heregulin: evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness",
      "volume": "56",
      "author": "Lewis",
      "year": "1996",
      "journal-title": "Cancer Res"
    },
    {
      "key": "10.1053/gast.2001.24844_bib27",
      "doi-asserted-by": "crossref",
      "first-page": "1385",
      "DOI": "10.1038/sj.onc.1201317",
      "article-title": "\u03b2-Heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast tumor cell line, MDA-MB-175",
      "volume": "15",
      "author": "Schaefer",
      "year": "1997",
      "journal-title": "Oncogene"
    },
    {
      "key": "10.1053/gast.2001.24844_bib28",
      "doi-asserted-by": "crossref",
      "first-page": "14661",
      "DOI": "10.1016/S0021-9258(17)36676-0",
      "article-title": "Coexpression of ErbB2 and ErbB3 proteins reconstitutes a high affinity receptor for heregulin",
      "volume": "269",
      "author": "Sliwkowski",
      "year": "1994",
      "journal-title": "J Biol Chem"
    },
    {
      "key": "10.1053/gast.2001.24844_bib29",
      "doi-asserted-by": "crossref",
      "first-page": "986",
      "DOI": "10.1101/gr.6.10.995",
      "article-title": "A novel method for real time quantitative PCR",
      "volume": "6",
      "author": "Gibson",
      "year": "1996",
      "journal-title": "Genome Res"
    },
    {
      "key": "10.1053/gast.2001.24844_bib30",
      "doi-asserted-by": "crossref",
      "first-page": "986",
      "DOI": "10.1101/gr.6.10.986",
      "article-title": "Real time quantitative PCR",
      "volume": "6",
      "author": "Heid",
      "year": "1996",
      "journal-title": "Genome Res"
    },
    {
      "key": "10.1053/gast.2001.24844_bib31",
      "doi-asserted-by": "crossref",
      "first-page": "6050",
      "DOI": "10.1038/sj.onc.1202993",
      "article-title": "Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells",
      "volume": "18",
      "author": "Aguilar",
      "year": "1999",
      "journal-title": "Oncogene"
    },
    {
      "key": "10.1053/gast.2001.24844_bib32",
      "doi-asserted-by": "crossref",
      "first-page": "2254",
      "DOI": "10.1172/JCI119400",
      "article-title": "Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2",
      "volume": "99",
      "author": "Sheng",
      "year": "1997",
      "journal-title": "J Clin Invest"
    },
    {
      "key": "10.1053/gast.2001.24844_bib33",
      "first-page": "732",
      "article-title": "Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes",
      "volume": "58",
      "author": "Brossart",
      "year": "1998",
      "journal-title": "Cancer Res"
    },
    {
      "key": "10.1053/gast.2001.24844_bib34",
      "doi-asserted-by": "crossref",
      "first-page": "305",
      "DOI": "10.1038/sj.onc.1202307",
      "article-title": "Regulation of cyclooxygenase-2 pathway by HER2 receptor",
      "volume": "18",
      "author": "Vadlamudi",
      "year": "1999",
      "journal-title": "Oncogene"
    },
    {
      "key": "10.1053/gast.2001.24844_bib35",
      "doi-asserted-by": "crossref",
      "first-page": "159",
      "DOI": "10.1016/S0092-8674(00)81333-1",
      "article-title": "Lessons from hereditary colorectal cancer",
      "volume": "87",
      "author": "Kinzler",
      "year": "1996",
      "journal-title": "Cell"
    },
    {
      "key": "10.1053/gast.2001.24844_bib36",
      "doi-asserted-by": "crossref",
      "first-page": "705",
      "DOI": "10.1016/S0092-8674(00)81433-6",
      "article-title": "Cyclooxygenase regulates angiogenesis induced by colon cancer cells",
      "volume": "93",
      "author": "Tsujii",
      "year": "1998",
      "journal-title": "Cell"
    },
    {
      "key": "10.1053/gast.2001.24844_bib37",
      "doi-asserted-by": "crossref",
      "first-page": "3336",
      "DOI": "10.1073/pnas.94.7.3336",
      "article-title": "Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential",
      "volume": "94",
      "author": "Tsujii",
      "year": "1997",
      "journal-title": "Proc Natl Acad Sci U S A"
    },
    {
      "key": "10.1053/gast.2001.24844_bib38",
      "doi-asserted-by": "crossref",
      "first-page": "1589",
      "DOI": "10.1172/JCI9621",
      "article-title": "DuBois RN. Host cyclo-oxygenase-2 modulates carcinoma growth",
      "volume": "105",
      "author": "Williams",
      "year": "2000",
      "journal-title": "J Clin Invest"
    },
    {
      "key": "10.1053/gast.2001.24844_bib39",
      "doi-asserted-by": "crossref",
      "first-page": "52",
      "DOI": "10.1002/(SICI)1097-4644(2000)77:34+<52::AID-JCB10>3.0.CO;2-X",
      "article-title": "The ErbB/HER family of receptor tyrosine kinases: a potential target for chemoprevention of epithelial neoplasms",
      "volume": "34",
      "author": "Kirschbaum",
      "year": "2000",
      "journal-title": "J Cell Biochem Suppl"
    },
    {
      "key": "10.1053/gast.2001.24844_bib40",
      "doi-asserted-by": "crossref",
      "first-page": "96",
      "DOI": "10.1046/j.1365-2559.2001.01084.x",
      "article-title": "Overexpression of HER2/new in solid tumors: an immunohistochemical survey",
      "volume": "38",
      "author": "Koeppen",
      "year": "2001",
      "journal-title": "Histopathology"
    },
    {
      "key": "10.1053/gast.2001.24844_bib41",
      "doi-asserted-by": "crossref",
      "first-page": "657",
      "DOI": "10.1073/pnas.94.2.657",
      "article-title": "EGF receptor activation induces nuclear targeting of COX-2, basolateral release of prostaglandins and mitogenesis in polarizing colon cancer cells",
      "volume": "94",
      "author": "Coffey",
      "year": "1997",
      "journal-title": "Proc Natl Acad Sci U S A"
    },
    {
      "key": "10.1053/gast.2001.24844_bib42",
      "doi-asserted-by": "crossref",
      "first-page": "120",
      "DOI": "10.1016/S1388-1981(99)00034-7",
      "article-title": "Growth stimulation and induction of epidermal growth factor receptor by overexpression of cyclooxygenases 1 and 2 in human colon carcinoma cells",
      "volume": "1438",
      "author": "Kinoshita",
      "year": "1999",
      "journal-title": "Biochim Biophys Acta"
    },
    {
      "key": "10.1053/gast.2001.24844_bib43",
      "doi-asserted-by": "crossref",
      "first-page": "201",
      "DOI": "10.1016/S0304-3835(98)00254-7",
      "article-title": "Decreased HER-2 tyrosine kinase expression in rectal mucosa of FAP patients following low-dose sulindac chemoprevention",
      "volume": "134",
      "author": "Winde",
      "year": "1998",
      "journal-title": "Cancer Lett"
    },
    {
      "key": "10.1053/gast.2001.24844_bib44",
      "doi-asserted-by": "crossref",
      "first-page": "272",
      "DOI": "10.1161/01.CIR.102.3.272",
      "article-title": "Trastuzumab in the treatment of metastatic breast cancer: anticancer therapy versus cardiotoxicity",
      "volume": "102",
      "author": "Feldman",
      "year": "2000",
      "journal-title": "Circulation"
    },
    {
      "key": "10.1053/gast.2001.24844_bib45",
      "first-page": "3",
      "article-title": "Site-directed irreversible inhibitors of the ErbB family of receptor tyrosine kinases as novel chemotherapeutic agents for cancer",
      "volume": "15",
      "author": "Fry",
      "year": "2000",
      "journal-title": "Anticancer Drug Des"
    }
  ],
  "container-title": "Gastroenterology",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0016508501646870?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0016508501646870?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2021,
        7,
        14
      ]
    ],
    "date-time": "2021-07-14T05:59:51Z",
    "timestamp": 1626242391000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0016508501646870"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2001,
        6
      ]
    ]
  },
  "references-count": 45,
  "journal-issue": {
    "issue": "7",
    "published-print": {
      "date-parts": [
        [
          2001,
          6
        ]
      ]
    }
  },
  "alternative-id": [
    "S0016508501646870"
  ],
  "URL": "http://dx.doi.org/10.1053/gast.2001.24844",
  "relation": {},
  "ISSN": [
    "0016-5085"
  ],
  "subject": [],
  "container-title-short": "Gastroenterology",
  "published": {
    "date-parts": [
      [
        2001,
        6
      ]
    ]
  }
}